Tarikh
:
8 Julai 2015 (Rabu)
Masa
:
11.00 pagi - 12.00 tengah hari
Tempat
: Dewan Anggerik, BPFK
Anjuran
: Merck Sharp & Dohme (M) Sdn Bhd
Mata CPD : A4 (1 mata / topik)
Time
|
Topic
|
Speaker / Facilitator
|
11.00 – 11.05 am
|
Opening Address
|
Mr Lim Jee Seong
Medical Advisor, Merck Sharp
& Dohme
|
11.05 – 11.35 am
|
The Role of Sitagliptin in Treatment of Patients with
Type-2 Diabetes: Lessons learned from TECOS CV Safety Trial
|
Dr Alexander Tan
Consultant Endocrinologist,
University of Malaya Medical Center
|
11.35 – 12.05 pm
|
CVD Risk Reduction in Dyslipidemia Management: Evidence
from IMPROVE-IT Trial
|
Prof. Dr Chee Kok Han
Consultant Cardiologist,
University of Malaya Medical Center
|
12.05 – 12.15 pm
|
Q&A
|
All
|